Lexicon Pharmaceuticals (LXRX) Inventory Average (2017 - 2026)
Lexicon Pharmaceuticals' (LXRX) quarterly Inventory Average came in at $278500.0 in Q1 2026, up 28.94% year-on-year from $216000.0 in Q1 2025, and up 26.88% on a QoQ basis from $219500.0 in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Inventory Average (2017 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 8 years of Inventory Average data on file, last reported at $278500.0 in Q1 2026.
- On a quarterly basis, Inventory Average rose 28.94% year-over-year to $278500.0 in Q1 2026; TTM through Mar 2026 was $278500.0, a 28.94% increase from a year earlier, with the FY2025 full-year figure at $256000.0, down 16.34% from the prior year.
- Inventory Average for Q1 2026 stood at $278500.0, up from $219500.0 in the prior quarter.
- Over the last five years, Inventory Average for LXRX reached as high as $610500.0 in Q3 2024 and fell as low as $163000.0 in Q3 2025.
- Historically, Inventory Average has averaged $337727.3 across 4 years, with a median of $278500.0 in 2026.
- Across the five-year window, Inventory Average soared 140.35% in 2024 and tumbled 73.3% in 2025, its largest moves.
- Year by year, Inventory Average stood at $358500.0 in 2023, then grew by 20.92% to $433500.0 in 2024, then sank by 49.37% to $219500.0 in 2025, then rose by 26.88% to $278500.0 in 2026.
- Per Business Quant data, the three most recent Inventory Average figures were $278500.0 in Q1 2026, $219500.0 in Q4 2025, and $163000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 644.91 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Lexicon Pharmaceuticals | 979.13 Mn | 808.47 Mn | 20.99 Mn | 278,500.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 278,500.00 |
| Dec 31, 2025 | 219,500.00 |
| Sep 30, 2025 | 163,000.00 |
| Jun 30, 2025 | 184,500.00 |
| Mar 31, 2025 | 216,000.00 |
| Dec 31, 2024 | 433,500.00 |
| Sep 30, 2024 | 610,500.00 |
| Jun 30, 2024 | 549,500.00 |
| Mar 31, 2024 | 447,500.00 |
| Dec 31, 2023 | 358,500.00 |
| Sep 30, 2023 | 254,000.00 |
| Jun 30, 2020 | 4.07 Mn |
| Mar 31, 2020 | 4.20 Mn |
| Dec 31, 2019 | 4.36 Mn |
| Sep 30, 2019 | 4.38 Mn |
| Jun 30, 2019 | 4.44 Mn |
| Mar 31, 2019 | 4.64 Mn |
| Dec 31, 2018 | 4.72 Mn |
| Sep 30, 2018 | 3.45 Mn |
| Jun 30, 2018 | 2.13 Mn |